🧴image loading
(from DailyMed)

Erythromycin and Benzoyl Peroxide 30 mg/g; 50 mg/g Gel, 23.3 g

by Rising Pharma Holdings, Inc. · 23.3 g in 1 JAR (64980-328-01)
NDC 64980-0328-01
🏷️ FDA NDC (as labeled) 64980-328-01 billing pads the product segment with a zero
This package
Contains23.3 g Cost per g$1.60 NADAC Per package$37.31 / 23.3 g Pack sizes2 compare ↓
Also priced by: Medicaid pays $1.85/unit · Part D plans $1.57/unit — full pricing hub ↓
Also comes in: 46.6 g 64980-0328-02
Rx only Generic On market Non-controlled
🗂️ Data synced Aug 27, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

🆔 Identity & classification

FDA NDC (as labeled) 64980-328-01
Product NDC 64980-328
11-digit billing NDC 64980032801
NCPDP billing unit GM — per gram (weight)
RxCUI 244374
UNII 63937KV33D, W9WZN9A0GM
Application # ANDA065385
SPL Set ID d449d7e2-5c25-406d-87ab-30809d292476
Established class (EPC) Macrolide; Macrolide Antimicrobial
Physiologic effect Decreased Sebaceous Gland Activity
Chemical class Macrolides
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2016-10-18
Route TOPICAL
Dosage form GEL
Substance ERYTHROMYCIN; BENZOYL PEROXIDE
GPI-14 90059902104010
GPI class Benzoyl Peroxide-Erythromycin
GCN Seq No 007678
GCN 85400
HICL code 003354
Ingredient (HICL) Erythromycin/Benzoyl Peroxide
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q5
Therapeutic class — intermediate (HIC2) Agents Acting Principally On The Skin
HIC3 code Q5W
Therapeutic class — specific (HIC3) Topical Antibiotics
AHFS code 08:12.12.04
AHFS class Erythromycin Antibiotics
FDB label name ERYTHROMYCIN-BENZOYL GEL
FDB brand name Erythromycin-Benzoyl Peroxide
Legend status F — Federal legend — prescription drug or device
TE code (Orange Book) AB · RLD · RS
Why two NDCs? The FDA registers this code as 64980-328-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 64980-0328-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏷️ RxNorm drug class

This medicine belongs to the Peroxides class.

Drug family (ATC) Peroxides
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

🏭 Manufacturer & labeler

LabelerRising Pharma Holdings, Inc.
Application holderRISING PHARMA HOLDINGS INC
FDA applicationANDA065385 (ANDA)
Labeler code64980
First marketedOct 2016
Product typeHuman Prescription Drug
Portfolio525 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

Label name ERYTHROMYCIN-BENZOYL GEL Ingredient Erythromycin/Benzoyl Peroxide
📖 What it is MedlinePlus · NLM

The combination of erythromycin and benzoyl peroxide is used to treat acne. Erythromycin and benzoyl peroxide are in a class of medications called topical antibiotics. The combination of erythromycin and benzoyl peroxide works by killing the bacteria that cause acne.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • This gel is a prescription treatment for acne vulgaris — the everyday kind of acne that causes pimples, blackheads, and red inflamed spots. It combines two ingredients that work to...
  • Apply it twice a day — once in the morning and once at night. Before you put it on, wash the area with soap, rinse with warm water, and gently pat your skin dry. Then apply the gel...
  • Yes — your pharmacist mixes this gel before dispensing it, and once it's mixed it must be kept in the refrigerator. Don't freeze it. It also has a 3-month expiration date from the...
  • The most common ones are skin dryness, peeling, redness, itching, or a mild burning sensation where you apply it. These are usually mild. If you notice hives or more serious skin i...
📖 Read our full Erythromycin and Benzoyl Peroxide Topical guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 3K9958V90M
    A liquid solvent derived from fermentation or chemical synthesis. In medicines, alcohol dissolves active ingredients, helps preserve the product, and improves how the body absorbs certain drugs.
  • UNII 4Q93RCW27E
    A synthetic polymer made from acrylic acid that's crosslinked for stability. It acts as a thickener and gelling agent in creams and gels, helping the medicine spread evenly and maintain its texture.
  • UNII F05Q2T2JA0
    Docusate sodium is a stool softener compound that helps medicines dissolve and move through the digestive tract. It acts as a surfactant, reducing surface tension in the intestines, and also serves as a wetting agent in tablet formulations.
  • UNII 55X04QC32I
    A strong alkaline chemical used to adjust and maintain the pH balance of liquid medicines. It helps keep the medicine stable and ensures it stays effective during storage.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

5 inactive ingredients listed in the exact product block matched to this NDC.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMedingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly $1.601 $37.31 / 23.3 g
Medicaid paysCMS SDUD · 12 mo $1.85 $43.13 / 23.3 g
Medicare drug plans payPart D · Q2 2026 $1.57 $36.68 / 23.3 g
NADAC price history (per g) — tap or hover for the price & month
Nov 2021 Oct 2022 Jan 2026 Aug 2026 $2.595 $1.532
▼ Down 35% over the last 20 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Erythromycin and Benzoyl Peroxide 68682-0901-46 Oceanside 1 kit $1.078 AB FDA listed save 33%
Erythromycin and Benzoyl Peroxide 68682-0900-23 Oceanside 1 kit $1.593 AB FDA listed save 1%
Erythromycin and Benzoyl Peroxide 30 mg/g; 50 mg/gthis 64980-0328-01 Rising 23.3 g $1.601 AB Availability likely
Benzamycin 00187-5205-46 Bausch 1 kit AB FDA listed
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2016
On the market since
Oct 2016
📍
2026
Currently FDA-listed
10 years listed
🔓
·
Generic on the market
this product is a generic
This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

🗺️ Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 64980-0328-01, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
10.1K
Units reimbursed last 4 qtrs
302K
Gross reimbursed last 4 qtrs
$559.1K
Avg / prescription
$55.36
Avg / unit
$1.8509
Latest quarter Q4 2025
2.7KRx
Medicaid pays / g
$1.8509
gross reimbursed
vs
NADAC / g
$1.6013
acquisition cost
=
Spread
+$0.2496
+16% vs cost
What Medicaid paid per g (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care
41% FFS 59% MCO
Fee-for-service · 4,171 Rx Managed care · 5,928 Rx
State Medicaid map
Alaska: no data reported AK Maine: 2,866 units · 205 per 100k residents ME Washington: 10,648 units · 136 per 100k residents WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 1,817 units · 31.7 per 100k residents MN Wisconsin: no data reported WI Michigan: 13,887 units · 138 per 100k residents MI New York: 11,044 units · 56.4 per 100k residents NY Vermont: 466 units · 72.0 per 100k residents VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: 1,561 units · 48.9 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: 14,934 units · 119 per 100k residents IL Indiana: 5,685 units · 82.8 per 100k residents IN Ohio: 21,017 units · 178 per 100k residents OH Pennsylvania: 18,103 units · 140 per 100k residents PA New Jersey: 7,223 units · 77.8 per 100k residents NJ Massachusetts: no data reported MA California: 112,575 units · 289 per 100k residents CA Utah: no data reported UT Colorado: 1,561 units · 26.6 per 100k residents CO Nebraska: 1,491 units · 75.4 per 100k residents NE Missouri: 256 units · 4.1 per 100k residents MO Kentucky: 4,869 units · 108 per 100k residents KY West Virginia: no data reported WV Virginia: 2,447 units · 28.1 per 100k residents VA Maryland: 7,736 units · 125 per 100k residents MD Connecticut: 699 units · 19.3 per 100k residents CT Rhode Island: 5,289 units · 483 per 100k residents RI Arizona: no data reported AZ New Mexico: 4,399 units · 208 per 100k residents NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: 19,058 units · 176 per 100k residents NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: 1,794 units · 16.3 per 100k residents GA D.C.: 5,079 units · 748 per 100k residents DC Hawaii: 1,515 units · 106 per 100k residents HI Texas: 4,292 units · 14.1 per 100k residents TX Florida: 19,735 units · 87.3 per 100k residents FL
Units reimbursed · per 100k residents
4.1748
gray = no data reported
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 D.C. 748 /100k
2 Rhode Island 483 /100k
3 California 289 /100k
4 New Mexico 208 /100k
5 Maine 205 /100k
6 Ohio 178 /100k
7 North Carolina 176 /100k
8 Pennsylvania 140 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

💊 Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
46 gs64980-0328-02 18,708 Rx · $1,046,363
23 gs this page64980-0328-01 10,099 Rx · $559,061
Drug total (last 4 qtrs): 28,807 Rx · 1,174,102 units · $1,605,425 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

📦 Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startStatus
64980-0328-01 You're viewing this 23.3 g in 1 JAR (64980-328-01) $1.60 / g $37.31 2016-10-18 Active
64980-0328-02 46.6 g in 1 JAR (64980-328-02) $1.05 / g $49.02 2016-10-18 Active

Per g, this pack runs about 52% above the cheapest pack (46.6 g in 1 JAR (64980-3, $1.05 vs $1.60 NADAC).

This pack accounts for about 35% of this product's recent Medicaid fills; most go to the 46 gs pack. See all packs ↓

Pack size FAQ

What quantity is in NDC 64980-0328-01?
NDC 64980-0328-01 contains 23.3 g — 23.3 g in 1 jar.
What is the difference between NDC 64980-0328-01 and NDC 64980-0328-02?
Both are Erythromycin and Benzoyl Peroxide 30 mg/g; 50 mg/g Gel — the drug itself is identical. NDC 64980-0328-01 is the 23.3 g package, while NDC 64980-0328-02 is the 46.6 g package. Per-g NADAC also differs: $1.60 here vs $1.05 for the 46.6 g pack.
What NDC number is used to bill for this package of Erythromycin and Benzoyl Peroxide 30 mg/g; 50 mg/g Gel?
Bill NDC 64980-0328-01 — the 11-digit billing format is 64980032801. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

📄 Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 19 words

INDICATIONS AND USAGE Erythromycin and Benzoyl Peroxide Topical Gel USP is indicated for the topical treatment of acne vulgaris.

⏱️ Dosage and Administration ~1 min read

DOSAGE AND ADMINISTRATION Erythromycin and Benzoyl Peroxide Topical Gel USP should be applied twice daily, morning and evening, or as directed by a physician, to affected areas after the skin is thoroughly washed, rinsed with warm water and gently patted dry. How Supplied and Compounding Directions Size (Net weight) NDC Benzoyl Peroxide Gel Active Erythromycin Powder (In Plastic Vial) 70% Ethyl Alcohol To Be Added 23.3 grams (as dispensed) 64980-328-01 20 grams 0.8 grams 3 mL 46.6 grams (as dispensed) 64980-328-02 40 grams 1.6 grams 6 mL Pharmacist Important - Prior to dispensing, tap vial until all powder flows freely.

Add indicated amount of room temperature 70% ETHYL ALCOHOL to vial (to the mark) and immediately shake vigorously to completely dissolve erythromycin, then immediately add this solution to gel and stir until homogeneous in appearance (1 to 1-1/2 minutes). Erythromycin and Benzoyl Peroxide Topical Gel USP should then be stored under refrigeration. Do not freeze.

Place a 3-month expiration date on the label. Note: Prior to reconstitution, store at room temperature between 15˚ and 30˚C (59˚-86˚F). After reconstitution , store under refrigeration between 2˚and 8˚C (36˚-46˚F).

Do not freeze. Keep tightly closed. Keep out of the reach of children.

Rx only Manufactured by: Lyne Laboratories, Inc., Brockton, MA 02301 Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816 Revised : 08/2025 PIR32846-00

Contraindications 22 words

CONTRAINDICATIONS Erythromycin and Benzoyl Peroxide Topical Gel USP is contraindicated in those individuals who have shown hypersensitivity to any of its components.

⚠️ Warnings 130 words

WARNINGS Pseudomembranous colitis has been reported with nearly all antibacterial agents, including erythromycin, and may range in severity from mild to life-threatening. Therefore, it is important to consider this diagnosis in patients who present with diarrhea subsequent to the administration of antibacterial agents. Treatment with antibacterial agents alters the normal flora of the colon and may permit overgrowth of clostridia.

Studies indicate that a toxin produced by Clostridium difficile is one primary cause of “antibiotic-associated colitis.” After the diagnosis of pseudomembranous colitis has been established, therapeutic measures should be initiated. Mild cases of pseudomembranous colitis usually respond to drug discontinuation alone. In moderate to severe cases, consideration should be given to management with fluids and electrolytes, protein supplementation and treatment with an antibacterial drug clinically effective against C. difficile colitis.

🤒 Adverse Reactions 94 words

ADVERSE REACTIONS In controlled clinical trials, the incidence of adverse reactions associated with the use of Erythromycin and Benzoyl Peroxide Topical Gel USP was approximately 3%. These were dryness and urticarial reaction. The following additional local adverse reactions have been reported occasionally: irritation of the skin including peeling, itching, burning sensation, erythema, inflammation of the face, eyes and nose, and irritation of the eyes.

Skin discoloration, oiliness and tenderness of the skin have also been reported. To report SUSPECTED ADVERSE REACTIONS, contact Rising Pharma Holdings, Inc. at 1-844-874-7464 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

🤰 Pregnancy 120 words

Pregnancy: Teratogenic Effects: Animal reproduction studies have not been conducted with Erythromycin and Benzoyl Peroxide Topical Gel USP or benzoyl peroxide. There was no evidence of teratogenicity or any other adverse effect on reproduction in female rats fed erythromycin base (up to 0.25% diet) prior to and during mating, during gestation and through weaning of two successive litters. There are no well-controlled trials in pregnant women with Erythromycin and Benzoyl Peroxide Topical Gel USP.

It also is not known whether Erythromycin and Benzoyl Peroxide Topical Gel USP can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. Erythromycin and Benzoyl Peroxide Topical Gel USP should be given to a pregnant woman only if clearly needed.

🧒 Pediatric Use 20 words

Pediatric Use: Safety and effectiveness of this product in pediatric patients below the age of 12 have not been established.

🧬 Clinical Pharmacology 149 words

CLINICAL PHARMACOLOGY The exact mechanism by which erythromycin reduces lesions of acne vulgaris is not fully known; however, the effect appears to be due in part to the antibacterial activity of the drug. Benzoyl peroxide has a keratolytic and desquamative effect which may also contribute to its efficacy. Benzoyl peroxide has been shown to be absorbed by the skin where it is converted to benzoic acid.

Microbiology Erythromycin acts by inhibition of protein synthesis in susceptible organisms by reversibly binding to 50 S ribosomal subunits, thereby inhibiting translocation of aminoacyl transfer-RNA and inhibiting polypeptide synthesis. Antagonism has been demonstrated in vitro between erythromycin, lincomycin, chloramphenicol and clindamycin. Benzoyl peroxide is an antibacterial agent which has been shown to be effective against Propionibacterium acnes , an anaerobe found in sebaceous follicles and comedones.

The antibacterial action of benzoyl peroxide is believed to be due to the release of active oxygen.

📦 How Supplied / Storage and Handling 182 words

How Supplied and Compounding Directions Size (Net weight) NDC Benzoyl Peroxide Gel Active Erythromycin Powder (In Plastic Vial) 70% Ethyl Alcohol To Be Added 23.3 grams (as dispensed) 64980-328-01 20 grams 0.8 grams 3 mL 46.6 grams (as dispensed) 64980-328-02 40 grams 1.6 grams 6 mL Pharmacist Important - Prior to dispensing, tap vial until all powder flows freely. Add indicated amount of room temperature 70% ETHYL ALCOHOL to vial (to the mark) and immediately shake vigorously to completely dissolve erythromycin, then immediately add this solution to gel and stir until homogeneous in appearance (1 to 1-1/2 minutes).

Erythromycin and Benzoyl Peroxide Topical Gel USP should then be stored under refrigeration. Do not freeze. Place a 3-month expiration date on the label.

Note: Prior to reconstitution, store at room temperature between 15˚ and 30˚C (59˚-86˚F). After reconstitution , store under refrigeration between 2˚and 8˚C (36˚-46˚F). Do not freeze.

Keep tightly closed. Keep out of the reach of children. Rx only Manufactured by: Lyne Laboratories, Inc., Brockton, MA 02301 Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816 Revised : 08/2025 PIR32846-00

📋 Description 216 words

DESCRIPTION Erythromycin and Benzoyl Peroxide Topical Gel USP contains erythromycin [(3R*, 4S*, 5S*, 6R*, 7R*, 9R*, 11R*, 12R*, 13S*, 14R*)-4-[(2,6-Dideoxy-3- C -methyl-3- 0 -methyl-α-L- ribo -hexopyranosyl)-oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-dimethylamino)-β-D- xylo -hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione]. Erythromycin is a macrolide antibiotic produced from a strain of Saccharopolyspora erythraea (formerly Streptomyces erythreus ). It is a base and readily forms salts with acids.

Chemically, erythromycin is (C 37 H 67 NO 13 ). It has the following structural formula: Erythromycin has the molecular weight of 733.94. It is a white crystalline powder and has a solubility of approximately 1 mg/mL in water and is soluble in alcohol at 25˚C.

Erythromycin and Benzoyl Peroxide Topical Gel USP also contains benzoyl peroxide for topical use. Benzoyl peroxide is an antibacterial and keratolytic agent. Chemically, benzoyl peroxide is (C 14 H 10 O 4 ).

It has the following structural formula: Benzoyl peroxide has the molecular weight of 242.23. It is a white granular powder and is sparingly soluble in water and alcohol and soluble in acetone, chloroform and ether. Each gram of Erythromycin and Benzoyl Peroxide Topical Gel USP contains, as dispensed, 30 mg (3%) of erythromycin and 50 mg (5%) of benzoyl peroxide in a base of purified water USP, carbomer 940 NF, ethyl alcohol 20%, sodium hydroxide NF, docusate sodium and fragrance.

LABEL LABEL 2

💬 Information for Patients 111 words

Information for Patients: Patients using Erythromycin and Benzoyl Peroxide Topical Gel USP should receive the following information and instructions: This medication is to be used as directed by the physician. It is for external use only. Avoid contact with the eyes, nose, mouth, and all mucous membranes.

This medication should not be used for any disorder other than that for which it was prescribed. Patients should not use any other topical acne preparation unless otherwise directed by physician. Patients should report to their physician any signs of local adverse reactions.

Erythromycin and Benzoyl Peroxide Topical Gel USP may bleach hair or colored fabric. Keep product refrigerated and discard after 3 months.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.